Biomanufacturing Facility MacDonald-Miller is partnering with a local biotechnology company on the expansion of their biomanufacturing facility as they continue their innovative work to transform cancer medicines. The current 283,000 sf project consists of five connected buildings that expand the company’s biomanufacturing capacity, providing greater control and flexibility to produce their own FDA-approved medications to…
